Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 442, 123 (13 July 2006) | doi:10.1038/442123a; Published online 12 July 2006
In brief
The German biotechnology company whose TGN1412 drug caused severe adverse reactions in six London volunteers in March has filed for bankruptcy. A statement from Würzburg-based TeGenero said that it was going into receivership because it would be impossible to secure the investment necessary to keep the 15-person company going.
To read this story in full you will need to login or make a payment (see right).
HTTP Status 500 -
type Exception report
message
description The server encountered an internal error () that prevented it from fulfilling this request.
exception
javax.servlet.ServletException: Servlet execution threw an exception
root cause
java.lang.OutOfMemoryError
note The full stack trace of the root cause is available in the Tomcat logs.